Annual Report

Overview

The report describes the company's transition into its first year of product commercialization, supported by two commercial-stage vaccines and expanded commercialization capabilities. It reports 387 employees and a group-wide employee training ratio of 100%. The ESG Report establishes Board-level accountability and a Sustainability Committee for ESG planning, risk management and materiality assessment. It also identifies six SDG priorities, including health, gender equality, responsible consumption and climate action.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2023
Period: 1 January 2023 – 31 December 2023
Publication date: 26 April 2024
Language: English
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services